Advances in understanding of the pathogenesis of acute respiratory distress syndrome

Respiration

Volumn 89, Issue 5, 2015, Pages 420-434

  Sharp, Charles ^a   Millar, Ann B ^a   Medford, Andrew R L ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Epithelial permeability; Pulmonary oedema

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CHEMOKINE; CYTOKINE; DEXAMETHASONE; FLUOROCARBON; HYDROCORTISONE; INTERLEUKIN 8; LEUKOCYTE ELASTASE INHIBITOR; METHYLPREDNISOLONE; NITRIC OXIDE; SIMVASTATIN; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN; MATRIX METALLOPROTEINASE; VASCULOTROPIN A;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE LUNG INJURY; ACUTE RESPIRATORY FAILURE; ADULT RESPIRATORY DISTRESS SYNDROME; EXTRACELLULAR MATRIX; EXTRACORPOREAL OXYGENATION; HUMAN; INTENSIVE CARE; MESENCHYMAL STEM CELL; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TERMINAL DISEASE; UNITED STATES; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA; ADULT; CAPILLARY PERMEABILITY; LUNG ALVEOLUS; METABOLISM; NEUTROPHIL; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; VASCULAR ENDOTHELIUM;

ADULT; ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; CAPILLARY PERMEABILITY; CYTOKINES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; NEUTROPHILS; PULMONARY ALVEOLI; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY MUCOSA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930272600     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000381102     Document Type: Review

References (136)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE: Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. Sloggett A: Memorandum of the Treatment of Injuries in War. London, Harrison and Sons, 1915, pp 115-122.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, et al: Incidence and outcomes of acute lung injury. N Engl J Med 2005; 353: 1685-1693.
4. Orme J, Romney JS, Hopkins RO, Pope D, Chan KJ, Thomsen G, et al: Pulmonary function and health-related quality of life in survivors of acute respiratory distress syndrome. Am J Respir Crit Care Med 2003; 167: 690-694.
5. Herridge MS, Tansey CM, Matté A, Tomlinson G, Diaz-Granados N, Cooper A, et al: Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011; 364: 1293-1304.
6. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
7. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, et al: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327-336.
8. Taylor RW, Zimmerman JL, Dellinger RP, Straube RC, Criner GJ, Davis K, et al: Low-dose inhaled nitric oxide in patients with acute lung injury: a randomized controlled trial. JAMA 2004; 291: 1603-1609.
9. Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, et al: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317: 1565-1570.
10. Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, et al: Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131: 954-963.
11. Guerin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al: Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013; 368: 2159-2168.
12. Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, et al: Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 2012; 379: 229-235.
13. Ferguson ND, Cook DJ, Guyatt GH, Mehta S, Hand L, Austin P, et al: High-frequency oscillation in early acute respiratory distress syndrome. N Engl J Med 2013; 368: 795-805.
14. Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R, et al: High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med 2013; 368: 806-813.
15. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM, et al: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374: 1351-1363.
16. McAuley DF, Laffey JG, O?Kane CM, Perkins GD, Mullan B, Trinder TJ, et al: Simvastatin in the acute respiratory distress syndrome. N Engl J Med 2014; 371: 1695-1703.
17. Zeiher BG, Artigas A, Vincent JL, Dmitrienko A, Jackson K, Thompson BT, et al: Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 2004; 32: 1695-1702.
18. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
19. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al: Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307: 2526-2533.
20. Hernu R, Wallet F, Thiollière F, Martin O, Richard JC, Schmitt Z, et al: An attempt to validate the modification of the American-European consensus definition of acute lung injury/ acute respiratory distress syndrome by the Berlin definition in a university hospital. Intensive Care Med 2013; 39: 2161-2170.
21. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 2000; 342: 1334-1349.
22. Thille AW, Esteban A, Fernandez-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errazuriz P, et al: Chronology of histological lesions in acute respiratory distress syndrome with diffuse alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 2013; 1: 395-401.
23. Matute-Bello G, Frevert CW, Martin TR: Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295:L379-L399.
24. Medford A, Millar A: Tolerability of bronchoalveolar lavage in ventilated patients with acute lung injury. Glob J Respir Care 2014; 1: 9-12.
25. Medford AR, Husain SA, Turki HM, Millar AB: Diagnosis of ventilator-associated pneumonia. J Crit Care 2009; 24: 473.e1-e6.
26. Grommes J, Soehnlein O: Contribution of neutrophils to acute lung injury. Mol Med 2011; 17: 293-307.
27. Armstrong L, Medford AR, Uppington KM, Robertson J, Witherden IR, Tetley TD, et al: Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 2004; 31: 241-245.
28. Davey A, McAuley DF, O?Kane CM: Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J 2011; 38: 959-970.
29. Ferrara N: Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) 1999; 77: 527-543.
30. Thickett DR, Armstrong L, Christie SJ, Millar AB: Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1601-1605.
31. Hanaoka M, Droma Y, Naramoto A, Honda T, Kobayashi T, Kubo K: Vascular endothelial growth factor in patients with high-altitude pulmonary edema. J Appl Physiol (1985) 2003; 94: 1836-1840.
32. Medford AR, Keen LJ, Bidwell JL, Millar AB: Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome. Thorax 2005; 60: 244-248.
33. Medford AR, Godinho SI, Keen LJ, Bidwell JL, Millar AB: Relationship between vascular endothelial growth factor +936 genotype and plasma/epithelial lining fluid vascular endothelial growth factor protein levels in patients with and at risk for ARDS. Chest 2009; 136: 457-464.
34. Thickett DR, Armstrong L, Millar AB: A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 2002; 166: 1332-1337.
35. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
36. Kaner RJ, Crystal RG: Compartmentalization of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 2001; 7: 240-246.
37. Barratt S, Medford AR, Millar AB: Vascular endothelial growth factor in acute lung injury and acute respiratory distress syndrome. Respiration 2014; 87: 329-342.
38. Medford AR, Millar AB: Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm? Thorax 2006; 61: 621-626.
39. Ferrara N, Gerber HP, LeCouter J: The biology of VEGF and its receptors. Nat Med 2003; 9: 669-676.
40. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, et al: The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-11954.
41. Robinson CJ, Stringer SE: The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 2001; 114: 853-865.
42. Wada T, Jesmin S, Gando S, Yanagida Y, Mizugaki A, Sultana SN, et al: The role of angiogenic factors and their soluble receptors in acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) associated with critical illness. J Inflamm (Lond) 2013; 10: 6.
43. Medford AR, Ibrahim NB, Millar AB: Vascular endothelial growth factor receptor and coreceptor expression in human acute respiratory distress syndrome. J Crit Care 2009; 24: 236-242.
44. Perkins GD, Roberts J, McAuley DF, Armstrong L, Millar A, Gao F, et al: Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury. Thorax 2005; 60: 153-158.
45. Medford AR, Douglas SK, Godinho SI, Uppington KM, Armstrong L, Gillespie KM, et al: Vascular endothelial growth factor (VEGF) isoform expression and activity in human and murine lung injury. Respir Res 2009; 10: 27.
46. Bates DO, Cui TG, Doughty JM, Winkler M, Sugiono M, Shields JD, et al: VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. Cancer Res 2002; 62: 4123-4131.
47. Harper SJ, Bates DO: VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat Rev Cancer 2008; 8: 880-887.
48. Eswarappa SM, Potdar AA, Koch WJ, Fan Y, Vasu K, Lindner D, et al: Programmed translational readthrough generates antiangiogenic VEGF-Ax. Cell 2014; 157: 1605-1618.
49. Varet J, Douglas SK, Gilmartin L, Medford AR, Bates DO, Harper SJ, et al: VEGF in the lung: a role for novel isoforms. Am J Physiol Lung Cell Mol Physiol 2010; 298:L768-L774.
50. Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, et al: Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway. Crit Care Med 2012; 40: 2041-2049.
51. Borensztajn K, Crestani B, Kolb M: Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers - insights from the bench side. Respiration 2013; 86: 441-452.
52. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al: Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071-2082.
53. Rhee CK, Lee SH, Yoon HK, Kim SC, Lee SY, Kwon SS, et al: Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. Respiration 2011; 82: 273-287.
54. Miller EJ, Cohen AB, Nagao S, Griffith D, Maunder RJ, Martin TR, et al: Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427-432.
55. Ware LB, Koyama T, Zhao Z, Janz DR, Wickersham N, Bernard GR, et al: Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit Care 2013; 17:R253.
56. Allen TC, Kurdowska A: Interleukin 8 and acute lung injury. Arch Pathol Lab Med 2014; 138: 266-269.
57. Kurdowska A, Miller EJ, Noble JM, Baughman RP, Matthay MA, Brelsford WG, et al: Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol 1996; 157: 2699-2706.
58. Krupa A, Kato H, Matthay MA, Kurdowska AK: Proinflammatory activity of anti-IL-8 autoantibody: IL-8 complexes in alveolar edema fluid from patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286: L1105-L1113.
59. Agrawal A, Zhuo H, Brady S, Levitt J, Steingrub J, Siegel MD, et al: Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials. Am J Physiol Lung Cell Mol Physiol 2012; 303:L634-L639.
60. Ahuja SK, Lee JC, Murphy PM: CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct. J Biol Chem 1996; 271: 225-232.
61. Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, et al: CXCR2/ CXCR2 ligand biology during lung transplant ischemia-reperfusion injury. J Immunol 2005; 175: 6931-6939.
62. Sue RD, Belperio JA, Burdick MD, Murray LA, Xue YY, Dy MC, et al: CXCR2 is critical to hyperoxia-induced lung injury. J Immunol 2004; 172: 3860-3868.
63. Chapman RW, Minnicozzi M, Celly CS, Phillips JE, Kung TT, Hipkin RW, et al: A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation. J Pharmacol Exp Ther 2007; 322: 486-493.
64. Jenkins RG, Su X, Su G, Scotton CJ, Camerer E, Laurent GJ, et al: Ligation of protease-activated receptor 1 enhances α v β 6 integrin-dependent TGF-β activation and promotes acute lung injury. J Clin Invest 2006; 116: 1606-1614.
65. Budinger GR, Chandel NS, Donnelly HK, Eisenbart J, Oberoi M, Jain M: Active transforming growth factor-beta1 activates the procollagen I promoter in patients with acute lung injury. Intensive Care Med 2005; 31: 121-128.
66. Akbarshahi H, Sam A, Chen C, Rosendahl AH, Andersson R: Early activation of pulmonary TGF-β1/Smad2 signaling in mice with acute pancreatitis-associated acute lung injury. Mediators Inflamm 2014; 2014: 148029.
67. Frank J, Roux J, Kawakatsu H, Su G, Dagenais A, Berthiaume Y, et al: Transforming growth factor-β1 decreases expression of the epithelial sodium channel αENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism. J Biol Chem 2003; 278: 43939-43950.
68. Willis BC, Kim KJ, Li X, Liebler J, Crandall ED, Borok Z: Modulation of ion conductance and active transport by TGF-beta 1 in alveolar epithelial cell monolayers. Am J Physiol Lung Cell Mol Physiol 2003; 285:L1192-L1200.
69. Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, et al: TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001; 107: 1537-1544.
70. Peters DM, Vadász I, Wujak L, Wygrecka M, Olschewski A, Becker C, et al: TGF-β directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury. Proc Natl Acad Sci USA 2014; 111:E374-E383.
71. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE: The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 1999; 274: 13586-13593.
72. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 1990; 86: 1976-1984.
73. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, Shevach EM: GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci USA 2009; 106: 13445-13450.
74. Böttinger EP, Factor VM, Tsang ML, Weatherbee JA, Kopp JB, Qian SW, et al: The recombinant proregion of transforming growth factor beta1 (latency-associated peptide) inhibits active transforming growth factor beta1 in transgenic mice. Proc Natl Acad Sci USA 1996; 93: 5877-5882.
75. Tang YJ, Xiao J, Huang XR, Zhang Y, Yang C, Meng XM, et al: Latent transforming growth factor-beta1 protects against bleomycin-induced lung injury in mice. Am J Respir Cell Mol Biol 2014; 51: 761-771.
76. Frank JA, Matthay MA: TGF-β and lung fluid balance in ARDS. Proc Natl Acad Sci USA 2014; 111: 885-886.
77. Synenki L, Chandel NS, Budinger GR, Donnelly HK, Topin J, Eisenbart J, et al: Bronchoalveolar lavage fluid from patients with acute lung injury/acute respiratory distress syndrome induces myofibroblast differentiation. Crit Care Med 2007; 35: 842-848.
78. Fernandez IE, Eickelberg O: The impact of TGF-beta on lung fibrosis: from targeting to biomarkers. Proc Am Thorac Soc 2012; 9: 111-116.
79. Uchida T, Shirasawa M, Ware LB, Kojima K, Hata Y, Makita K, et al: Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 2006; 173: 1008-1015.
80. Schmidt AM, Yan SD, Yan SF, Stern DM: The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108: 949-955.
81. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al: Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 2005; 83: 876-886.
82. Calfee CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, et al: Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008; 63: 1083-1089.
83. Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Maeda S, Yamagishi S: Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome. Clin Biochem 2011; 44: 601-604.
84. Laffon M, Pittet JF, Modelska K, Matthay MA, Young DM: Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am J Respir Crit Care Med 1999; 160: 1443-1449.
85. Bao Z, Ye Q, Gong W, Xiang Y, Wan H: Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int Immunopharmacol 2010; 10: 259-263.
86. Osman MO, Kristensen JU, Jacobsen NO, Lausten SB, Deleuran B, Deleuran M, et al: A monoclonal anti-interleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut 1998; 43: 232-239.
87. Folkesson HG, Matthay MA, Hébert CA, Broaddus VC: Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995; 96: 107-116.
88. Sharma AK, LaPar DJ, Zhao Y, Li L, Lau CL, Kron IL, et al: Natural killer T cell-derived IL-17 mediates lung ischemia-reperfusion injury. Am J Respir Crit Care Med 2011; 183: 1539-1549.
89. Hudock KM, Liu Y, Mei J, Marino RC, Hale JE, Dai N, et al: Delayed resolution of lung inflammation in Il-1rn -/- mice reflects elevated IL-17A/granulocyte colony-stimulating factor expression. Am J Respir Cell Mol Biol 2012; 47: 436-444.
90. Ognibene FP, Martin SE, Parker MM, Schlesinger T, Roach P, Burch C, et al: Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med 1986; 315: 547-551.
91. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al: Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
92. Narasaraju T, Yang E, Samy RP, Ng HH, Poh WP, Liew AA, et al: Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 2011; 179: 199-210.
93. Ichikawa A, Kuba K, Morita M, Chida S, Tezuka H, Hara H, et al: CXCL10-CXCR3 enhances the development of neutrophil-mediated fulminant lung injury of viral and nonviral origin. Am J Respir Crit Care Med 2013; 187: 65-77.
94. Summers C, Singh NR, White JF, Mackenzie IM, Johnston A, Solanki C, et al: Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. Thorax 2014; 69: 623-629.
95. Shah D, Romero F, Stafstrom W, Duong M, Summer R: Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2014; 306:L152-L161.
96. Soehnlein O, Oehmcke S, Ma X, Rothfuchs AG, Frithiof R, van Rooijen N, et al: Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 2008; 32: 405-412.
97. Donnelly SC, MacGregor I, Zamani A, Gordon MW, Robertson CE, Steedman DJ, et al: Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151: 1428-1433.
98. Fujii M, Miyagi Y, Bessho R, Nitta T, Ochi M, Shimizu K: Effect of a neutrophil elastase inhibitor on acute lung injury after cardiopulmonary bypass. Interact Cardiovasc Thorac Surg 2010; 10: 859-862.
99. Delacourt C, Hérigault S, Delclaux C, Poncin A, Levame M, Harf A, et al: Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor. Am J Respir Cell Mol Biol 2002; 26: 290-297.
100. Sugamata R, Dobashi H, Nagao T, Yamamoto K, Nakajima N, Sato Y, et al: Contribution of neutrophil-derived myeloperoxidase in the early phase of fulminant acute respiratory distress syndrome induced by influenza virus infection. Microbiol Immunol 2012; 56: 171-182.
101. Auten RL, Whorton MH, Nicholas Mason S: Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am J Respir Cell Mol Biol 2002; 26: 391-397.
102. Dunsmore SE, Rannels DE: Extracellular matrix biology in the lung. Am J Physiol 1996; 270:L3-L27.
103. Greenlee KJ, Werb Z, Kheradmand F: Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 2007; 87: 69-98.
104. Gushima Y, Ichikado K, Suga M, Okamoto T, Iyonaga K, Sato K, et al: Expression of matrix metalloproteinases in pigs with hyperoxia-induced acute lung injury. Eur Respir J 2001; 18: 827-837.
105. Kim JY, Choeng HC, Ahn C, Cho SH: Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis. Yonsei Med J 2009; 50: 68-77.
106. Eichler W, Bechtel JF, Schumacher J, Wermelt JA, Klotz KF, Bartels C: A rise of MMP-2 and MMP-9 in bronchoalveolar lavage fluid is associated with acute lung injury after cardiopulmonary bypass in a swine model. Perfusion 2003; 18: 107-113.
107. Lanchou J, Corbel M, Tanguy M, Germain N, Boichot E, Theret N, et al: Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients. Crit Care Med 2003; 31: 536-542.
108. O?Kane CM, McKeown SW, Perkins GD, Bassford CR, Gao F, Thickett DR, et al: Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med 2009; 37: 2242-2249.
109. Lukkarinen H, Hogmalm A, Lappalainen U, Bry K: Matrix metalloproteinase-9 deficiency worsens lung injury in a model of bronchopulmonary dysplasia. Am J Respir Cell Mol Biol 2009; 41: 59-68.
110. Warner RL, Beltran L, Younkin EM, Lewis CS, Weiss SJ, Varani J, et al: Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol 2001; 24: 537-544.
111. Carney DE, McCann UG, Schiller HJ, Gatto LA, Steinberg J, Picone AL, et al: Metalloproteinase inhibition prevents acute respiratory distress syndrome. J Surg Res 2001; 99: 245-252.
112. Steinberg J, Halter J, Schiller HJ, Dasilva M, Landas S, Gatto LA, et al: Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J Surg Res 2003; 111: 185-195.
113. Wiener-Kronish JP, Broaddus VC, Albertine KH, Gropper MA, Matthay MA, Staub NC: Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest 1988; 82: 1422-1429.
114. Matthay MA, Folkesson HG, Clerici C: Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002; 82: 569-600.
115. Ware LB, Matthay MA: Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 163: 1376-1383.
116. Matthay MA: Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med 2014; 189: 1301-1308.
117. Roux J, McNicholas CM, Carles M, Goolaerts A, Houseman BT, Dickinson DA, et al: IL-8 inhibits cAMP-stimulated alveolar epithelial fluid transport via a GRK2/PI3K-dependent mechanism. FASEB J 2013; 27: 1095-1106.
118. Berger G, Guetta J, Klorin G, Badarneh R, Braun E, Brod V, et al: Sepsis impairs alveolar epithelial function by downregulating Na-KATPase pump. Am J Physiol Lung Cell Mol Physiol 2011; 301:L23-L30.
119. Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, et al: Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med 2012; 18: 759-765.
120. Galani V, Tatsaki E, Bai M, Kitsoulis P, Lekka M, Nakos G, et al: The role of apoptosis in the pathophysiology of Acute Respiratory Distress Syndrome (ARDS): an up-to-date cellspecific review. Pathol Res Pract 2010; 206: 145-150.
121. Rudkowski JC, Barreiro E, Harfouche R, Goldberg P, Kishta O, D?Orleans-Juste P, et al: Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis. Am J Physiol Lung Cell Mol Physiol 2004; 286:L793-L800.
122. Lucas R, Verin AD, Black SM, Catravas JD: Regulators of endothelial and epithelial barrier integrity and function in acute lung injury. Biochem Pharmacol 2009; 77: 1763-1772.
123. Carnesecchi S, Dunand-Sauthier I, Zanetti F, Singovski G, Deffert C, Donati Y, et al: NOX1 is responsible for cell death through STAT3 activation in hyperoxia and is associated with the pathogenesis of acute respiratory distress syndrome. Int J Clin Exp Pathol 2014; 7: 537-551.
124. Terasaki Y, Terasaki M, Urushiyama H, Nagasaka S, Takahashi M, Kunugi S, et al: Role of survivin in acute lung injury: epithelial cells of mice and humans. Lab Invest 2013; 93: 1147-1163.
125. Matthay MA, Ware LB, Zimmerman GA: The acute respiratory distress syndrome. J Clin Invest 2012; 122: 2731-2740.
126. Vestweber D, Winderlich M, Cagna G, Nottebaum AF: Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol 2009; 19: 8-15.
127. Obinata H, Hla T: Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol 2012; 34: 73-91.
128. Fox ED, Heffernan DS, Cioffi WG, Reichner JS: Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrity. Crit Care 2013; 17:R226.
129. Sun S, Sursal T, Adibnia Y, Zhao C, Zheng Y, Li H, et al: Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS One 2013; 8:e59989.
130. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, et al: DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genom 2004; 19: 331-342.
131. Cabrera-Benitez NE, Parotto M, Post M, Han B, Spieth PM, Cheng WE, et al: Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition. Crit Care Med 2012; 40: 510-517.
132. Heise RL, Stober V, Cheluvaraju C, Hollingsworth JW, Garantziotis S: Mechanical stretch induces epithelial-mesenchymal transition in alveolar epithelia via hyaluronan activation of innate immunity. J Biol Chem 2011; 286: 17435-17444.
133. Bhattacharya J, Matthay MA: Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu Rev Physiol 2013; 75: 593-615.
134. Chapman HA, Li X, Alexander JP, Brumwell A, Lorizio W, Tan K, et al: Integrin α6β4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest 2011; 121: 2855-2862.
135. Hayes M, Curley G, Ansari B, Laffey JG: Clinical review: stem cell therapies for acute lung injury/acute respiratory distress syndrome -hope or hype? Crit Care 2012; 16: 205.
136. Cardenes N, Caceres E, Romagnoli M, Rojas M: Mesenchymal stem cells: a promising therapy for the acute respiratory distress syndrome. Respiration 2013; 85: 267-278.